These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 7636871)
1. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases. Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871 [TBL] [Abstract][Full Text] [Related]
2. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid. Schirmeister T J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963 [TBL] [Abstract][Full Text] [Related]
3. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Barrett AJ; Kembhavi AA; Brown MA; Kirschke H; Knight CG; Tamai M; Hanada K Biochem J; 1982 Jan; 201(1):189-98. PubMed ID: 7044372 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks. Schirmeister T Biopolymers; 1999; 51(1):87-97. PubMed ID: 10380356 [TBL] [Abstract][Full Text] [Related]
5. Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors. Schaschke N; Assfalg-Machleidt I; Machleidt W; Moroder L FEBS Lett; 1998 Jan; 421(1):80-2. PubMed ID: 9462845 [TBL] [Abstract][Full Text] [Related]
6. Aziridinyl peptides as inhibitors of cysteine proteases: effect of a free carboxylic acid function on inhibition. Schirmeister T; Peric M Bioorg Med Chem; 2000 Jun; 8(6):1281-91. PubMed ID: 10896108 [TBL] [Abstract][Full Text] [Related]
7. Aziridide-based inhibitors of cathepsin L: synthesis, inhibition activity, and docking studies. Vicik R; Busemann M; Gelhaus C; Stiefl N; Scheiber J; Schmitz W; Schulz F; Mladenovic M; Engels B; Leippe M; Baumann K; Schirmeister T ChemMedChem; 2006 Oct; 1(10):1126-41. PubMed ID: 16933358 [TBL] [Abstract][Full Text] [Related]
8. Deacylation and reacylation for a series of acyl cysteine proteases, including acyl groups derived from novel chromophoric substrates. Doran JD; Tonge PJ; Mort JS; Carey PR Biochemistry; 1996 Sep; 35(38):12487-94. PubMed ID: 8823184 [TBL] [Abstract][Full Text] [Related]
9. E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group. Schaschke N; Assfalg-Machleidt I; Machleidt W; Turk D; Moroder L Bioorg Med Chem; 1997 Sep; 5(9):1789-97. PubMed ID: 9354234 [TBL] [Abstract][Full Text] [Related]
11. The crystal structure of human cathepsin L complexed with E-64. Fujishima A; Imai Y; Nomura T; Fujisawa Y; Yamamoto Y; Sugawara T FEBS Lett; 1997 Apr; 407(1):47-50. PubMed ID: 9141479 [TBL] [Abstract][Full Text] [Related]
12. Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases. Schad C; Baum U; Frank B; Dietzel U; Mattern F; Gomes C; Ponte-Sucre A; Moll H; Schurigt U; Schirmeister T Antimicrob Agents Chemother; 2016 Feb; 60(2):797-805. PubMed ID: 26596939 [TBL] [Abstract][Full Text] [Related]
13. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives. Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357 [TBL] [Abstract][Full Text] [Related]
14. E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases. Barrett AJ; Kembhavi AA; Hanada K Acta Biol Med Ger; 1981; 40(10-11):1513-7. PubMed ID: 7044005 [TBL] [Abstract][Full Text] [Related]
15. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides. Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686 [TBL] [Abstract][Full Text] [Related]
16. Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type 1 domains, is an inhibitor of papain-like cysteine proteinases. Lenarcic B; Krishnan G; Borukhovich R; Ruck B; Turk V; Moczydlowski E J Biol Chem; 2000 May; 275(20):15572-7. PubMed ID: 10748022 [TBL] [Abstract][Full Text] [Related]
17. New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8. Fey P; Chartomatsidou R; Kiefer W; Mottram JC; Kersten C; Schirmeister T Eur J Med Chem; 2018 Aug; 156():587-597. PubMed ID: 30029081 [TBL] [Abstract][Full Text] [Related]
18. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi. Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025 [TBL] [Abstract][Full Text] [Related]
19. Miraziridine A: natures blueprint towards protease class-spanning inhibitors. Schaschke N Bioorg Med Chem Lett; 2004 Feb; 14(4):855-7. PubMed ID: 15012981 [TBL] [Abstract][Full Text] [Related]
20. Azapeptides as inhibitors and active site titrants for cysteine proteinases. Xing R; Hanzlik RP J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]